Furthermore, it’s important to point here that upon analysis of publicly available TARGET datasets for much larger cohorts of AML and ALL; ADAM6 and PRSS1 exhibited the same observed pattern of differential expression in acute leukemia patients compared to normal controls. This evidence concerns the gene ADAM6 and acute lymphoblastic leukemia.